The potential role of therapeutic antibodies in the regulation of rejection

Transplant Proc. 1995 Oct;27(5 Suppl 1):13-7.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use
  • Antigens, CD / immunology
  • Antigens, Neoplasm*
  • CD52 Antigen
  • Glycoproteins*
  • Graft Rejection / immunology
  • Graft Rejection / prevention & control*
  • HLA Antigens / immunology
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Immunosuppressive Agents / therapeutic use
  • Intercellular Adhesion Molecule-1 / immunology
  • Isoantibodies / therapeutic use
  • Lymphocyte Function-Associated Antigen-1 / immunology
  • Mice / immunology
  • T-Lymphocytes / immunology

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, Neoplasm
  • CD52 Antigen
  • CD52 protein, human
  • Glycoproteins
  • HLA Antigens
  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents
  • Isoantibodies
  • Lymphocyte Function-Associated Antigen-1
  • Intercellular Adhesion Molecule-1